Cochrane2020IaEN
Cochrane Review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Zusammenfassung
Primäre Thromboseprophylaxe zur Vermeidung von venösen Thromboembolien bei ambulanten Tumorpatienten unter Chemotherapie - Rutjes, AWS - 2020 \| Cochrane Library
[Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008500.pub5/full/de#main-content)
[Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008500.pub5/full/de#)
Cookies
Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Co
Kerninformationen
858.CD008500.pub5/full/de#)
[Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention
- [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008500.pub5/information/de#history)
- [Conclusions changed](https:...
ctives
To assess the efficacy and safety of primary thromboprophylaxis for VTE in ambulatory cancer patients receiving chemotherapy compared with placebo or no thromboprophylaxis, or an active control intervention.
### Search methods
For this update, the Cochrane Vascular Information Specialist s...
cebo, or comparing two different anticoagulants.
### Data collection and analysis
We extracted data on risk of bias, participant characteristics, interventions, and outcomes including symptomatic VTE and major bleeding as the primary effectiveness and safety outcomes, respectively. We applied GRAD...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2021
Cochrane Review: Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Cochrane2021
Cochrane Review: Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
Cochrane2024
Cochrane Review: Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
Cochrane2023
Cochrane Review: Prophylactic anticoagulants for non-hospitalised people with COVID-19
Cochrane2021
Cochrane Review: Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
Cochrane2021
Cochrane Review: Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
Cochrane2022
Cochrane Review: Anticoagulants for people hospitalised with COVID-19
Cochrane2020